Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy.

Sleigh JN, Barreiro-Iglesias A, Oliver PL, Biba A, Becker T, Davies KE, Becker CG, Talbot K.

Hum Mol Genet. 2014 Feb 15;23(4):855-69. doi: 10.1093/hmg/ddt477. Epub 2013 Sep 25.

2.

SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy.

See K, Yadav P, Giegerich M, Cheong PS, Graf M, Vyas H, Lee SG, Mathavan S, Fischer U, Sendtner M, Winkler C.

Hum Mol Genet. 2014 Apr 1;23(7):1754-70. doi: 10.1093/hmg/ddt567. Epub 2013 Nov 11.

3.

Proteomic assessment of a cell model of spinal muscular atrophy.

Wu CY, Whye D, Glazewski L, Choe L, Kerr D, Lee KH, Mason RW, Wang W.

BMC Neurosci. 2011 Mar 8;12:25. doi: 10.1186/1471-2202-12-25.

4.

Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.

Hua Y, Sahashi K, Rigo F, Hung G, Horev G, Bennett CF, Krainer AR.

Nature. 2011 Oct 5;478(7367):123-6. doi: 10.1038/nature10485.

5.

The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy.

Ahmad S, Wang Y, Shaik GM, Burghes AH, Gangwani L.

Hum Mol Genet. 2012 Jun 15;21(12):2745-58. doi: 10.1093/hmg/dds102. Epub 2012 Mar 14.

6.

Limited phenotypic effects of selectively augmenting the SMN protein in the neurons of a mouse model of severe spinal muscular atrophy.

Lee AJ, Awano T, Park GH, Monani UR.

PLoS One. 2012;7(9):e46353. doi: 10.1371/journal.pone.0046353. Epub 2012 Sep 27.

7.

Recapitulation of spinal motor neuron-specific disease phenotypes in a human cell model of spinal muscular atrophy.

Wang ZB, Zhang X, Li XJ.

Cell Res. 2013 Mar;23(3):378-93. doi: 10.1038/cr.2012.166. Epub 2012 Dec 4.

8.

A new model to study spinal muscular atrophy: neurite degeneration and cell death is counteracted by BCL-X(L) Overexpression in motoneurons.

Garcera A, Mincheva S, Gou-Fabregas M, Caraballo-Miralles V, Lladó J, Comella JX, Soler RM.

Neurobiol Dis. 2011 Jun;42(3):415-26. doi: 10.1016/j.nbd.2011.02.003. Epub 2011 Feb 16.

PMID:
21333739
9.

Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy.

Miller N, Feng Z, Edens BM, Yang B, Shi H, Sze CC, Hong BT, Su SC, Cantu JA, Topczewski J, Crawford TO, Ko CP, Sumner CJ, Ma L, Ma YC.

J Neurosci. 2015 Apr 15;35(15):6038-50. doi: 10.1523/JNEUROSCI.3716-14.2015.

10.

Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy.

Murray LM, Lee S, Bäumer D, Parson SH, Talbot K, Gillingwater TH.

Hum Mol Genet. 2010 Feb 1;19(3):420-33. doi: 10.1093/hmg/ddp506. Epub 2009 Nov 2.

11.

Dilysine motifs in exon 2b of SMN protein mediate binding to the COPI vesicle protein α-COP and neurite outgrowth in a cell culture model of spinal muscular atrophy.

Custer SK, Todd AG, Singh NN, Androphy EJ.

Hum Mol Genet. 2013 Oct 15;22(20):4043-52. doi: 10.1093/hmg/ddt254. Epub 2013 May 31.

12.

Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

Burghes AH, Beattie CE.

Nat Rev Neurosci. 2009 Aug;10(8):597-609. doi: 10.1038/nrn2670. Epub 2009 Jul 8. Review.

13.

Spinal muscular atrophy and the antiapoptotic role of survival of motor neuron (SMN) protein.

Anderton RS, Meloni BP, Mastaglia FL, Boulos S.

Mol Neurobiol. 2013 Apr;47(2):821-32. doi: 10.1007/s12035-013-8399-5. Epub 2013 Jan 13. Review.

PMID:
23315303
14.

Smn deficiency causes neuritogenesis and neurogenesis defects in the retinal neurons of a mouse model of spinal muscular atrophy.

Liu H, Beauvais A, Baker AN, Tsilfidis C, Kothary R.

Dev Neurobiol. 2011 Feb;71(2):153-69. doi: 10.1002/dneu.20840.

15.
16.

Restoration of SMN to Emx-1 expressing cortical neurons is not sufficient to provide benefit to a severe mouse model of Spinal Muscular Atrophy.

Taylor AS, Glascock JJ, Rose FF Jr, Lutz C, Lorson CL.

Transgenic Res. 2013 Oct;22(5):1029-36. doi: 10.1007/s11248-013-9702-y. Epub 2013 Mar 20.

17.
18.

Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy.

Wishart TM, Mutsaers CA, Riessland M, Reimer MM, Hunter G, Hannam ML, Eaton SL, Fuller HR, Roche SL, Somers E, Morse R, Young PJ, Lamont DJ, Hammerschmidt M, Joshi A, Hohenstein P, Morris GE, Parson SH, Skehel PA, Becker T, Robinson IM, Becker CG, Wirth B, Gillingwater TH.

J Clin Invest. 2014 Apr;124(4):1821-34. doi: 10.1172/JCI71318. Epub 2014 Mar 3.

19.

Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.

Ohuchi K, Funato M, Kato Z, Seki J, Kawase C, Tamai Y, Ono Y, Nagahara Y, Noda Y, Kameyama T, Ando S, Tsuruma K, Shimazawa M, Hara H, Kaneko H.

Stem Cells Transl Med. 2016 Feb;5(2):152-63. doi: 10.5966/sctm.2015-0059. Epub 2015 Dec 18.

PMID:
26683872
20.

The spinal muscular atrophy disease protein SMN is linked to the Rho-kinase pathway via profilin.

Nölle A, Zeug A, van Bergeijk J, Tönges L, Gerhard R, Brinkmann H, Al Rayes S, Hensel N, Schill Y, Apkhazava D, Jablonka S, O'mer J, Srivastav RK, Baasner A, Lingor P, Wirth B, Ponimaskin E, Niedenthal R, Grothe C, Claus P.

Hum Mol Genet. 2011 Dec 15;20(24):4865-78. doi: 10.1093/hmg/ddr425. Epub 2011 Sep 14.

Items per page

Supplemental Content

Write to the Help Desk